PRNAF

Alterity Therapeutics (PK) (PRNAF)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:PRNAF
DataOraFonteTitoloSimboloCompagnia
04/03/202414:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
02/10/202314:44Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersUSOTC:PRNAFAlterity Therapeutics Ltd (PK)
31/08/202315:15Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
21/06/202312:09Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)USOTC:PRNAFAlterity Therapeutics Ltd (PK)
31/08/202218:25Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)USOTC:PRNAFAlterity Therapeutics Ltd (PK)
26/08/202223:19Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:PRNAFAlterity Therapeutics Ltd (PK)
03/06/202212:06Edgar (US Regulatory)Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)USOTC:PRNAFAlterity Therapeutics Ltd (PK)
06/01/202122:16Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:PRNAFAlterity Therapeutics Ltd (PK)
23/12/202022:07Edgar (US Regulatory)Securities Registration (foreign Private Issuer) (f-3)USOTC:PRNAFAlterity Therapeutics Ltd (PK)
16/12/202022:50Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)USOTC:PRNAFAlterity Therapeutics Ltd (PK)
02/12/202022:07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:PRNAFAlterity Therapeutics Ltd (PK)
24/11/202012:03Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:PRNAFAlterity Therapeutics Ltd (PK)
26/05/202012:16Edgar (US Regulatory)Report of Foreign Issuer (6-k)USOTC:PRNAFAlterity Therapeutics Ltd (PK)
18/04/201922:47Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:PRNAFAlterity Therapeutics Ltd (PK)
27/03/201911:10Edgar (US Regulatory)Amended Report of Foreign Issuer (6-k/a)USOTC:PRNAFAlterity Therapeutics Ltd (PK)
06/11/201416:10Edgar (US Regulatory)Securities Registration (ads, Immediate) (f-6ef)USOTC:PRNAFAlterity Therapeutics Ltd (PK)
31/10/201422:00Edgar (US Regulatory)Notification That Form 20-f Will Be Submitted Late (nt 20-f)USOTC:PRNAFAlterity Therapeutics Ltd (PK)
24/07/201421:39Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:PRNAFAlterity Therapeutics Ltd (PK)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:PRNAF
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network